These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28188132)

  • 1. miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma.
    Bartolomé-Izquierdo N; de Yébenes VG; Álvarez-Prado AF; Mur SM; Lopez Del Olmo JA; Roa S; Vazquez J; Ramiro AR
    Blood; 2017 Apr; 129(17):2408-2419. PubMed ID: 28188132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth.
    Bujisic B; De Gassart A; Tallant R; Demaria O; Zaffalon L; Chelbi S; Gilliet M; Bertoni F; Martinon F
    Blood; 2017 Apr; 129(17):2420-2428. PubMed ID: 28167662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-181a negatively regulates NF-κB signaling and affects activated B-cell-like diffuse large B-cell lymphoma pathogenesis.
    Kozloski GA; Jiang X; Bhatt S; Ruiz J; Vega F; Shaknovich R; Melnick A; Lossos IS
    Blood; 2016 Jun; 127(23):2856-66. PubMed ID: 26941399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.
    Bedekovics T; Hussain S; Feldman AL; Galardy PJ
    Blood; 2016 Mar; 127(12):1564-74. PubMed ID: 26702068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
    Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
    Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases.
    Gormley RP; Madan R; Dulau AE; Xu D; Tamas EF; Bhattacharyya PK; LeValley A; Xue X; Kumar P; Sparano J; Ramesh KH; Pulijaal V; Cannizzaro L; Walsh D; Ioachim HL; Ratech H
    Am J Clin Pathol; 2005 Nov; 124(5):790-8. PubMed ID: 16203284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.
    Schneider C; Setty M; Holmes AB; Maute RL; Leslie CS; Mussolin L; Rosolen A; Dalla-Favera R; Basso K
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8185-90. PubMed ID: 24843176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes.
    Rivas MA; Durmaz C; Kloetgen A; Chin CR; Chen Z; Bhinder B; Koren A; Viny AD; Scharer CD; Boss JM; Elemento O; Mason CE; Melnick AM
    Front Immunol; 2021; 12():688493. PubMed ID: 34621263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation.
    Rivas MA; Meydan C; Chin CR; Challman MF; Kim D; Bhinder B; Kloetgen A; Viny AD; Teater MR; McNally DR; Doane AS; Béguelin W; Fernández MTC; Shen H; Wang X; Levine RL; Chen Z; Tsirigos A; Elemento O; Mason CE; Melnick AM
    Nat Immunol; 2021 Feb; 22(2):240-253. PubMed ID: 33432228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.
    Muppidi JR; Schmitz R; Green JA; Xiao W; Larsen AB; Braun SE; An J; Xu Y; Rosenwald A; Ott G; Gascoyne RD; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Vaidehi N; Staudt LM; Cyster JG
    Nature; 2014 Dec; 516(7530):254-8. PubMed ID: 25274307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth.
    Pizzi M; Piazza F; Agostinelli C; Fuligni F; Benvenuti P; Mandato E; Casellato A; Rugge M; Semenzato G; Pileri SA
    Oncotarget; 2015 Mar; 6(9):6544-52. PubMed ID: 25788269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of immunoglobulin variable genes supports a germinal center experienced normal counterpart in primary cutaneous diffuse large B-cell lymphoma, leg-type.
    Pham-Ledard A; Prochazkova-Carlotti M; Deveza M; Laforet MP; Beylot-Barry M; Vergier B; Parrens M; Feuillard J; Merlio JP; Gachard N
    J Dermatol Sci; 2017 Nov; 88(2):238-246. PubMed ID: 28838616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth.
    Hashwah H; Schmid CA; Kasser S; Bertram K; Stelling A; Manz MG; Müller A
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9701-9706. PubMed ID: 28831000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
    Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
    Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms.
    Sewastianik T; Straubhaar JR; Zhao JJ; Samur MK; Adler K; Tanton HE; Shanmugam V; Nadeem O; Dennis PS; Pillai V; Wang J; Jiang M; Lin J; Huang Y; Brooks D; Bouxsein M; Dorfman DM; Pinkus GS; Robbiani DF; Ghobrial IM; Budnik B; Jarolim P; Munshi NC; Anderson KC; Carrasco RD
    Blood; 2021 Apr; 137(14):1905-1919. PubMed ID: 33751108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models.
    Mossadegh-Keller N; Brisou G; Beyou A; Nadel B; Roulland S
    Front Immunol; 2021; 12():683597. PubMed ID: 34335584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated CARD11 accelerates germinal center kinetics, promoting mTORC1 and terminal differentiation.
    Wray-Dutra MN; Chawla R; Thomas KR; Seymour BJ; Arkatkar T; Sommer KM; Khim S; Trapnell C; James RG; Rawlings DJ
    J Exp Med; 2018 Sep; 215(9):2445-2461. PubMed ID: 30127060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
    Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
    Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy.
    Dahl M; Kristensen LS; Grønbæk K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
    Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
    Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.